TREACE MEDICAL CONCEPTS INC. - COMMON STOCK
7.8300
22-November-24 16:44:58
15 minutes delayed
Stocks
-0.1100
-1.39%
Today's range
7.7460 - 8.0200
ISIN
N/A
Source
NASDAQ
-
Treace Medical Concepts Appoints New Directors
04 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
-
Treace Announces First Patient Treated in Mini3D™ Lapiplasty® Clinical Study
01 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
-
Treace Announces New ALIGN3D™ Data at the 2021 AOFAS Annual Meeting
23 Sep 2021 16:15:00 By Nasdaq GlobeNewswire
-
Treace Announces Launch of Adductoplasty™ Instrumented Midfoot Correction System
13 Sep 2021 16:56:55 By Nasdaq GlobeNewswire
-
Treace Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference
02 Sep 2021 16:05:00 By Nasdaq GlobeNewswire
-
Treace Announces New Supportive ALIGN3D™ Data to be Presented at the 2021 AOFAS Annual Meeting
01 Sep 2021 10:00:00 By Nasdaq GlobeNewswire
-
Treace Medical Concepts Reports Second Quarter 2021 Financial Results
05 Aug 2021 16:05:02 By Nasdaq GlobeNewswire
-
Treace to Report Second Quarter 2021 Financial Results on August 5, 2021
27 Jul 2021 16:05:00 By Nasdaq GlobeNewswire
-
Treace Medical Concepts Reports First Quarter 2021 Financial Results
25 May 2021 16:05:00 By Nasdaq GlobeNewswire
-
Treace Announces Interim Results from ALIGN3D™ Clinical Study at ACFAS 2021
19 May 2021 13:30:00 By Nasdaq GlobeNewswire
-
Treace to Report First Quarter 2021 Financial Results on May 25, 2021
18 May 2021 08:00:01 By Nasdaq GlobeNewswire
-
Treace to Announce Interim Results from ALIGN3D™ at ACFAS 2021
12 May 2021 08:00:02 By Nasdaq GlobeNewswire